Literature DB >> 8319712

An unusual patient with the neonatal Marfan phenotype and mitochondrial complex I deficiency.

J Christodoulou1, R Petrova-Benedict, B H Robinson, V Jay, J T Clarke.   

Abstract

We report the case of a 16-month-old male with the neonatal appearance of Marfan syndrome (NMS), with dolichocephaly, a long midface, deep-set eyes, arachnodactyly, dislocated lenses and carciovascular abnormalities. The presence of persistent lactic acidosis led to studies which disclosed mitochondrial complex I deficiency. We speculate that this unusual association may be due to the combination of an inherited mutation affecting complex I activity along with a de novo mutation disrupting the corresponding locus and an adjacent NMS locus on the homologous autosome. The possibility that the phenotype observed in this patient is directly due to the mitochondrial defect cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319712     DOI: 10.1007/bf01955904

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  24 in total

1.  Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene.

Authors:  H C Dietz; G R Cutting; R E Pyeritz; C L Maslen; L Y Sakai; G M Corson; E G Puffenberger; A Hamosh; E J Nanthakumar; S M Curristin
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

2.  A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies.

Authors:  Y Goto; I Nonaka; S Horai
Journal:  Nature       Date:  1990-12-13       Impact factor: 49.962

3.  Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

Authors:  D C Wallace; G Singh; M T Lott; J A Hodge; T G Schurr; A M Lezza; L J Elsas; E K Nikoskelainen
Journal:  Science       Date:  1988-12-09       Impact factor: 47.728

4.  Deficient expression of the gene coding for decorin in a lethal form of Marfan syndrome.

Authors:  L Pulkkinen; K Kainulainen; T Krusius; P Mäkinen; J Schollin; K H Gustavsson; L Peltonen
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

5.  Diagnosis and management of infantile marfan syndrome.

Authors:  R P Morse; S Rockenmacher; R E Pyeritz; S P Sanders; F R Bieber; A Lin; P MacLeod; B Hall; J M Graham
Journal:  Pediatrics       Date:  1990-12       Impact factor: 7.124

6.  The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia.

Authors:  B H Robinson; D M Glerum; W Chow; R Petrova-Benedict; R Lightowlers; R Capaldi
Journal:  Pediatr Res       Date:  1990-11       Impact factor: 3.756

7.  Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.

Authors:  R W Moreadith; M L Batshaw; T Ohnishi; D Kerr; B Knox; D Jackson; R Hruban; J Olson; B Reynafarje; A L Lehninger
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Fatal combined defects in mitochondrial multienzyme complexes in two siblings.

Authors:  B H Robinson; W Chow; R Petrova-Benedict; J T Clarke; M I Van Allen; L E Becker; J E Boulton; I Ragan
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

9.  Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes.

Authors:  B Lee; M Godfrey; E Vitale; H Hori; M G Mattei; M Sarfarazi; P Tsipouras; F Ramirez; D W Hollister
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

10.  A mitochondrial myopathy with a deficiency of respiratory chain NADH-CoQ reductase activity.

Authors:  J A Morgan-Hughes; P Darveniza; D N Landon; J M Land; J B Clark
Journal:  J Neurol Sci       Date:  1979-09       Impact factor: 3.181

View more
  3 in total

1.  NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings.

Authors:  S Pitkänen; A Feigenbaum; R Laframboise; B H Robinson
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy.

Authors:  Ali Reza Tavasoli; Parastoo Rostami; Mahmoud Reza Ashrafi; Parvaneh Karimzadeh
Journal:  Iran J Child Neurol       Date:  2017

Review 3.  Emerging evidence for targeting mitochondrial metabolic dysfunction in cancer therapy.

Authors:  Yueming Zhu; Angela Elizabeth Dean; Nobuo Horikoshi; Collin Heer; Douglas R Spitz; David Gius
Journal:  J Clin Invest       Date:  2018-08-31       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.